ALSTOM (AOMD.DE) Fundamental Analysis & Valuation

FRA:AOMDFR0010220475

Current stock price

16.63 EUR
-6.06 (-26.71%)
Last:

This AOMD.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. AOMD.DE Profitability Analysis

1.1 Basic Checks

  • AOMD had positive earnings in the past year.
  • AOMD had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: AOMD reported negative net income in multiple years.
  • In multiple years AOMD reported negative operating cash flow during the last 5 years.
AOMD.DE Yearly Net Income VS EBIT VS OCF VS FCFAOMD.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B -2B 3B

1.2 Ratios

  • AOMD has a Return On Assets of 0.92%. This is in the lower half of the industry: AOMD underperforms 65.74% of its industry peers.
  • Looking at the Return On Equity, with a value of 3.03%, AOMD is doing worse than 62.04% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 3.50%, AOMD is doing worse than 62.96% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AOMD is significantly below the industry average of 8.67%.
  • The last Return On Invested Capital (3.50%) for AOMD is above the 3 year average (2.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.92%
ROE 3.03%
ROIC 3.5%
ROA(3y)-0.31%
ROA(5y)-0.39%
ROE(3y)-1.2%
ROE(5y)-1.48%
ROIC(3y)2.36%
ROIC(5y)1.96%
AOMD.DE Yearly ROA, ROE, ROICAOMD.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

1.3 Margins

  • The Profit Margin of AOMD (1.68%) is worse than 62.04% of its industry peers.
  • In the last couple of years the Profit Margin of AOMD has declined.
  • AOMD has a worse Operating Margin (4.01%) than 60.19% of its industry peers.
  • In the last couple of years the Operating Margin of AOMD has declined.
  • Looking at the Gross Margin, with a value of 12.59%, AOMD is doing worse than 93.52% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AOMD has declined.
Industry RankSector Rank
OM 4.01%
PM (TTM) 1.68%
GM 12.59%
OM growth 3Y69.79%
OM growth 5Y-11.95%
PM growth 3YN/A
PM growth 5Y-32.37%
GM growth 3Y3.78%
GM growth 5Y-6.9%
AOMD.DE Yearly Profit, Operating, Gross MarginsAOMD.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1

2. AOMD.DE Health Analysis

2.1 Basic Checks

  • AOMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for AOMD has been increased compared to 1 year ago.
  • Compared to 5 years ago, AOMD has more shares outstanding
  • Compared to 1 year ago, AOMD has an improved debt to assets ratio.
AOMD.DE Yearly Shares OutstandingAOMD.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
AOMD.DE Yearly Total Debt VS Total AssetsAOMD.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 0.83, we must say that AOMD is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of AOMD (0.83) is worse than 77.78% of its industry peers.
  • AOMD has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • AOMD has a Debt to Equity ratio (0.31) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACC0.5
WACC7.05%
AOMD.DE Yearly LT Debt VS Equity VS FCFAOMD.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 0.97 indicates that AOMD may have some problems paying its short term obligations.
  • AOMD has a worse Current ratio (0.97) than 87.04% of its industry peers.
  • AOMD has a Quick Ratio of 0.97. This is a bad value and indicates that AOMD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.74, AOMD is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.74
AOMD.DE Yearly Current Assets VS Current LiabilitesAOMD.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

5

3. AOMD.DE Growth Analysis

3.1 Past

  • AOMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 208.61%, which is quite impressive.
  • Measured over the past years, AOMD shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -29.24% on average per year.
  • AOMD shows a small growth in Revenue. In the last year, the Revenue has grown by 4.58%.
  • AOMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.65% yearly.
EPS 1Y (TTM)208.61%
EPS 3YN/A
EPS 5Y-29.24%
EPS Q2Q%275.83%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y6.12%
Revenue growth 5Y17.65%
Sales Q2Q%3.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.96% on average over the next years. This is quite good.
  • Based on estimates for the next years, AOMD will show a small growth in Revenue. The Revenue will grow by 4.33% on average per year.
EPS Next Y26.58%
EPS Next 2Y24.16%
EPS Next 3Y19.88%
EPS Next 5Y13.96%
Revenue Next Year3.67%
Revenue Next 2Y4.5%
Revenue Next 3Y4.64%
Revenue Next 5Y4.33%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AOMD.DE Yearly Revenue VS EstimatesAOMD.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
AOMD.DE Yearly EPS VS EstimatesAOMD.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5 2

5

4. AOMD.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • AOMD is valuated rather expensively with a Price/Earnings ratio of 24.46.
  • AOMD's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.89, AOMD is valued at the same level.
  • With a Price/Forward Earnings ratio of 7.61, the valuation of AOMD can be described as very cheap.
  • 95.37% of the companies in the same industry are more expensive than AOMD, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.50, AOMD is valued rather cheaply.
Industry RankSector Rank
PE 24.46
Fwd PE 7.61
AOMD.DE Price Earnings VS Forward Price EarningsAOMD.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • AOMD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AOMD is cheaper than 70.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.01
AOMD.DE Per share dataAOMD.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AOMD's earnings are expected to grow with 19.88% in the coming years.
PEG (NY)0.92
PEG (5Y)N/A
EPS Next 2Y24.16%
EPS Next 3Y19.88%

4

5. AOMD.DE Dividend Analysis

5.1 Amount

  • AOMD has a Yearly Dividend Yield of 2.03%. Purely for dividend investing, there may be better candidates out there.
  • In the last 3 months the price of AOMD has falen by -36.33%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 1.40, AOMD pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, AOMD has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.03%

5.2 History

  • The dividend of AOMD decreases each year by -59.58%.
Dividend Growth(5Y)-59.58%
Div Incr Years0
Div Non Decr Years0
AOMD.DE Yearly Dividends per shareAOMD.DE Yearly Dividends per shareYearly Dividends per share 2017 2021 2022 2023 0.05 0.1 0.15 0.2

5.3 Sustainability

  • 11.39% of the earnings are spent on dividend by AOMD. This is a low number and sustainable payout ratio.
DP11.39%
EPS Next 2Y24.16%
EPS Next 3Y19.88%
AOMD.DE Yearly Income VS Free CF VS DividendAOMD.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B -2B 3B
AOMD.DE Dividend Payout.AOMD.DE Dividend Payout, showing the Payout Ratio.AOMD.DE Dividend Payout.PayoutRetained Earnings

AOMD.DE Fundamentals: All Metrics, Ratios and Statistics

ALSTOM

FRA:AOMD (4/17/2026, 7:00:00 PM)

16.63

-6.06 (-26.71%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)01-20
Earnings (Next)05-13
Inst Owners70.09%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap7.68B
Revenue(TTM)18.77B
Net Income(TTM)316.00M
Analysts71.82
Price Target26.61 (60.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.03%
Yearly Dividend0.06
Dividend Growth(5Y)-59.58%
DP11.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.38%
PT rev (3m)3.6%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 24.46
Fwd PE 7.61
P/S 0.41
P/FCF N/A
P/OCF 20.06
P/B 0.74
P/tB N/A
EV/EBITDA 7.01
EPS(TTM)0.68
EY4.09%
EPS(NY)2.19
Fwd EY13.14%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)0.83
OCFY4.98%
SpS40.63
BVpS22.55
TBVpS-1.17
PEG (NY)0.92
PEG (5Y)N/A
Graham Number18.573 (11.68%)
Profitability
Industry RankSector Rank
ROA 0.92%
ROE 3.03%
ROCE 4.97%
ROIC 3.5%
ROICexc 3.6%
ROICexgc 14.09%
OM 4.01%
PM (TTM) 1.68%
GM 12.59%
FCFM N/A
ROA(3y)-0.31%
ROA(5y)-0.39%
ROE(3y)-1.2%
ROE(5y)-1.48%
ROIC(3y)2.36%
ROIC(5y)1.96%
ROICexc(3y)2.46%
ROICexc(5y)2.07%
ROICexgc(3y)19.81%
ROICexgc(5y)25.47%
ROCE(3y)3.35%
ROCE(5y)2.78%
ROICexgc growth 3Y15.87%
ROICexgc growth 5Y-22.05%
ROICexc growth 3Y72.68%
ROICexc growth 5Y-24.96%
OM growth 3Y69.79%
OM growth 5Y-11.95%
PM growth 3YN/A
PM growth 5Y-32.37%
GM growth 3Y3.78%
GM growth 5Y-6.9%
F-Score8
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 2.04
Cap/Depr 58.83%
Cap/Sales 2.63%
Interest Coverage 250
Cash Conversion 24.07%
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.74
Altman-Z 0.83
F-Score8
WACC7.05%
ROIC/WACC0.5
Cap/Depr(3y)53.94%
Cap/Depr(5y)55.69%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)208.61%
EPS 3YN/A
EPS 5Y-29.24%
EPS Q2Q%275.83%
EPS Next Y26.58%
EPS Next 2Y24.16%
EPS Next 3Y19.88%
EPS Next 5Y13.96%
Revenue 1Y (TTM)4.58%
Revenue growth 3Y6.12%
Revenue growth 5Y17.65%
Sales Q2Q%3.24%
Revenue Next Year3.67%
Revenue Next 2Y4.5%
Revenue Next 3Y4.64%
Revenue Next 5Y4.33%
EBIT growth 1Y32.57%
EBIT growth 3Y80.18%
EBIT growth 5Y3.59%
EBIT Next Year112.41%
EBIT Next 3Y36.96%
EBIT Next 5Y23.55%
FCF growth 1Y87.6%
FCF growth 3YN/A
FCF growth 5Y17.8%
OCF growth 1Y183.99%
OCF growth 3YN/A
OCF growth 5Y14.6%

ALSTOM / AOMD.DE Fundamental Analysis FAQ

What is the fundamental rating for AOMD stock?

ChartMill assigns a fundamental rating of 3 / 10 to AOMD.DE.


What is the valuation status for AOMD stock?

ChartMill assigns a valuation rating of 4 / 10 to ALSTOM (AOMD.DE). This can be considered as Fairly Valued.


What is the profitability of AOMD stock?

ALSTOM (AOMD.DE) has a profitability rating of 2 / 10.


What are the PE and PB ratios of ALSTOM (AOMD.DE) stock?

The Price/Earnings (PE) ratio for ALSTOM (AOMD.DE) is 24.46 and the Price/Book (PB) ratio is 0.74.


What is the financial health of ALSTOM (AOMD.DE) stock?

The financial health rating of ALSTOM (AOMD.DE) is 1 / 10.